Stephen D Ryder
Stephen D Ryder
Nottingham University Hospitals NHS Trust
Verified email at
Cited by
Cited by
EASL Clinical Practice Guidelines: management of hepatitis C virus infection
European Association For The Study Of The Liver
Journal of hepatology 55 (2), 245-264, 2011
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
GP Aithal, JA Thomas, PV Kaye, A Lawson, SD Ryder, I Spendlove, ...
Gastroenterology 135 (4), 1176-1184, 2008
Prednisolone or pentoxifylline for alcoholic hepatitis
MR Thursz, P Richardson, M Allison, A Austin, M Bowers, CP Day, ...
New England Journal of Medicine 372 (17), 1619-1628, 2015
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol …
R Williams, R Aspinall, M Bellis, G Camps-Walsh, M Cramp, A Dhawan, ...
The Lancet 384 (9958), 1953-1997, 2014
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
SD Ryder
Gut 52 (suppl 3), iii1-iii8, 2003
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
Mannose binding protein gene mutations associated with unusual and severe infections in adults
JA Summerfield, S Ryder, M Sumiya, M Thursz, A Gorchein, MA Monteil, ...
The Lancet 345 (8954), 886-889, 1995
Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology
MM Skelly, PD James, SD Ryder
Journal of hepatology 35 (2), 195-199, 2001
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ...
Journal of viral hepatitis 21, 5-33, 2014
Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study
SD Ryder
Gut 53 (3), 451-455, 2004
The UK‐PBC risk scores: derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis
M Carbone, SJ Sharp, S Flack, D Paximadas, K Spiess, C Adgey, ...
Hepatology 63 (3), 930-950, 2016
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ...
The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ...
Nature communications 6 (1), 8019, 2015
Strategies to manage hepatitis C virus (HCV) disease burden
H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ...
Journal of viral hepatitis 21, 60-89, 2014
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
G Rogers, P Hewson, D Wright, R Anderson, M Cramp, S Jackson, ...
Health technology assessment (Winchester, England) 11 (34), 1-206, 2007
Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine
PD Richardson, PD James, SD Ryder
Journal of hepatology 33 (3), 371-375, 2000
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ...
Journal of hepatology 73 (4), 842-854, 2020
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection
K Agarwal, SK Fung, TT Nguyen, W Cheng, E Sicard, SD Ryder, ...
Journal of hepatology 62 (3), 533-540, 2015
The system can't perform the operation now. Try again later.
Articles 1–20